Search results
Results from the WOW.Com Content Network
Meningococcal polysaccharide vaccine (MPSV-4), Menomune, has been available since the 1970s. It may be used if MCV-4 is not available, and is the only meningococcal vaccine licensed for people older than 55. Information about who should receive the meningococcal vaccine is available from the CDC. [24]
NmVac4-A/C/Y/W-135 is the commercial name for a polysaccharide vaccine that protects against meningococcal meningitis caused by Neisseria meningitidis, specifically the serotypes A, C, Y, and W-135. This vaccine is part of a broader group of meningococcal vaccines.
Penbraya is a pentavalent conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. [4] Invasive meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to serious conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis. [5]
Pfizer’s new meningococcal vaccine, Penbraya, protects against five kinds of bacteria and could soon be an option that offers people broad protection from meningococcal disease with fewer shots.
A new vaccine from Pfizer has been approved by the Food and Drug Administration as the first shot of its kind to address multiple strains of meningococcal disease, the company said Oct. 20.. After ...
“The vaccine helps prevent serious illnesses such as pneumonia, meningitis and bloodstream infections, which can be particularly dangerous for older adults and those with health issues,” Dr ...
The first vaccine to prevent meningococcal serogroup B (meningitis B) disease was approved by the European Commission on 22 January 2013. [12] Vaccines offer significant protection from three to five years (plain polysaccharide vaccine Menomune, Mencevax and NmVac-4) to more than eight years (conjugate vaccine Menactra). [13] [14]
The Meningococcal Conjugate Vaccine (MCV4) is given between the ages of 11 and 12 years of age. As many as half the people who get meningococcal vaccines have mild side effect which include redness or pain at injection site; small percentage of people develop a fever; These symptoms usually only last 1 or 2 days [2]